DETERMINATION OF THE CAMPTOTHECIN DERIVATIVES CPT-11 AND SN-38 IN URINE AND SALIVA BY MICELLAR ELECTROKINECTIC CHROMATOGRAPHY

被引:3
|
作者
Marques, F. F. C. [1 ,2 ]
Cunha, A. L. M. C. [1 ]
Sa, A. [1 ]
Aucelio, R. Q. [1 ]
机构
[1] Pontificia Univ Catolica Rio de Janeiro, Dept Quim, BR-22451900 Rio De Janeiro, RJ, Brazil
[2] Univ Fed Fluminense, Dept Quim Analit, Rio De Janeiro, Brazil
关键词
Irinotecan; Micellar electrokinetic capillary chromatography; Normal stacking mode; SN-38; TISSUE-CULTURE MEDIA; LIQUID-CHROMATOGRAPHY; IRINOTECAN; CAPILLARY; PHARMACOKINETICS; METABOLISM; PLASMA; AGENTS;
D O I
10.1080/00032719.2012.677985
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
The anti-cancer synthetic drug irinotecan (CPT-11) and its active metabolite SN-38 have been determined by micellar electrokinetic capillary chromatography (MEKC). The detection of the analytes was made at 368 nm and their separation took less than 7 min using a borate buffer (pH 8.8 at 25 mmol L-1) solution containing sodium dodecyl sulfate (45 mmol L-1) and acetonitrile (13.5% v/v). On-line analyte concentration (normal stacking mode) and the use of a highly sensitive cell (Z shaped cell) improved detection limits (at the 10(-8) mol L-1 level). Recovery in fortified human saliva was 108 +/- 5%, in agreement with the result achieved with the reference HPLC method. For the analysis of urine from rats submitted to a single dose of CPT-11 and SN-38, camptothecin was used as internal standard enabling recoveries close to 100% when compared to the results achieved using HPLC.
引用
收藏
页码:1849 / 1861
页数:13
相关论文
共 50 条
  • [31] In Vitro Binding and Partitioning of Irinotecan (CPT-11) and its Metabolite, SN-38, in Human Blood
    Olivier Combes
    Jérôme Barré
    Jean-Claude Duché
    Laurent Vernillet
    Yves Archimbaud
    Michael P. Marietta
    Jean-Paul Tillement
    Saïk Urien
    Investigational New Drugs, 2000, 18 : 1 - 5
  • [32] In vitro binding and partitioning of irinotecan (CPT-11) and its metabolite, SN-38, in human blood
    Combes, O
    Barré, J
    Duché, JC
    Vernillet, L
    Archimbaud, Y
    Marietta, MP
    Tillement, JP
    Urien, S
    INVESTIGATIONAL NEW DRUGS, 2000, 18 (01) : 1 - 5
  • [33] The anticancer prodrug CPT-11 is a potent inhibitor of acetylcholinesterase but is rapidly catalyzed to SN-38 by butyrylcholinesterase
    Morton, CL
    Wadkins, RM
    Danks, MK
    Potter, PM
    CANCER RESEARCH, 1999, 59 (07) : 1458 - 1463
  • [34] Effective irinotecan (CPT-11)-containing liposomes: Intraliposomal conversion to the active metabolite SN-38
    Sadzuka, Y
    Hirotsu, S
    Hirota, S
    JAPANESE JOURNAL OF CANCER RESEARCH, 1999, 90 (02): : 226 - 232
  • [35] Effects of SN-38 (an active metabolite of CPT-11) on responses of human and rodent cells to irradiation
    Sasai, K
    Guo, GZ
    Shibuya, K
    Oya, N
    Shibata, T
    Nagata, Y
    Hiraoka, M
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1998, 42 (04): : 785 - 788
  • [36] Sensitive determination of irinotecan (CPT-11) and its active metabolite SN-38 in human serum using liquid chromatography-electrospray mass spectrometry
    Ragot, S
    Marquet, P
    Lachâtre, F
    Rousseau, A
    Lacassie, E
    Gaulier, JM
    Dupuy, JL
    Lachâtre, G
    JOURNAL OF CHROMATOGRAPHY B, 1999, 736 (1-2): : 175 - 184
  • [37] Simultaneous population pharmacokinetic (PPK) modeling of irinotecan (CPT-11) and its major metabolites, SN-38 and SN-38G.
    Xiao, AJ
    Fiedler-Kelly, J
    Schaaf, LJ
    Elfring, GL
    Sardella, S
    Redman, M
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2002, 71 (02) : P63 - P63
  • [38] Role of ABCG2 as a biomarker for predicting resistance to CPT-11/SN-38 in lung cancer
    Bessho, Y
    Oguri, T
    Achiwa, H
    Muramatsu, H
    Maeda, H
    Niimi, T
    Sato, S
    Ueda, R
    CANCER SCIENCE, 2006, 97 (03) : 192 - 198
  • [39] Irinotecan (CPT-11) pharmacokinetics-pharmacodynamics: The clinical relevance of prolonged SN-38 circulation.
    Mathijssen, RH
    Verweij, J
    Kehrer, DF
    Sparreboom, A
    CLINICAL CANCER RESEARCH, 2001, 7 (11) : 3737S - 3737S
  • [40] Uptake mechanism of irinotecan (CPT-11) and its metabolite (SN-38) by hamster intestinal cells.
    Kobayashi, K
    Bouscarel, B
    Matsuzaki, Y
    Ceryak, S
    Fromm, H
    GASTROENTEROLOGY, 1998, 114 (04) : A626 - A627